ClinicalTrials.Veeva

Menu

Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation

W

Wesameldin Abelrahman Soltan

Status

Unknown

Conditions

Parasternal Intercostal Muscle Thickness
Weaning From Mechanical Ventilation

Treatments

Diagnostic Test: Parasternal intercostal muscles thickness ultrasound indicies

Study type

Observational

Funder types

Other

Identifiers

NCT04779463
Parasternal Intercostals US

Details and patient eligibility

About

Assessment of the the parasternal intercostal muscles thickness by the ultrasonography as a weaning predictor of the mechanically ventilated patients

Full description

impact of parasternal muscle thickness on the weaning process of the mechanically ventilated patients in ICU

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Any patient invasively mechanically ventilated at least 24 hours on a pressure support mode who is clinically stable and ready to undergo a spontaneous breathing trial.

All patients will be:

  • Alert.
  • Afebrile.
  • Adequate cough with absence of excessive tracheobronchial secretion.
  • Fraction of inspired oxygen (FIO2) of <50%.
  • PEEP ≤8 cmH2O.
  • PaO2/FiO2 > 150.
  • pH ≥7.35 and ≤7.45.
  • Respiratory rate (RR) ≤35 breaths/min.
  • Hemodynamically stable in the absence of vasopressors.
  • Stable metabolic and endocrinal status.
  • Euglycemic state.
  • Adequate mentation (no sedation or stable neurologic patient).

Exclusion criteria

Diaphragmatic paralysis (detected by ultrasonography).Patients&Methods. 6

  • Pregnant women.
  • Age: >= 18 years.
  • Surgical dressings over measurement point which would preclude ultrasound exam.
  • Underweight patients (Body mass index <18.5 kg/m2).
  • Morbidly obese patient (Body mass index ≥ 40 kg/m2).
  • Primary neuro-muscular diseases.
  • Central coditions with depressed central respiratory drive (encephalitis, and brainstem haemorrhage/ischaemia).
  • Repiratory conditions with reduced pulmonary compliance (interstitial lung disease, pulmonary hemorrhage, and diffuse pulmonary infiltrates) or reduced chest wall compliance (kyphoscoliosis).
  • Cardiac conditions with high risk of weaning induced pulmonary edema (congestive heart failure, cyanotic heart diease, pulmonary hypertension, and ischemic heart diease).
  • Addict patients.
  • Patients with psychiatric disease.

Trial design

40 participants in 1 patient group

Mechanical Ventilated patients
Description:
All patients are invasively mechanically ventilated at least 24 hours, and are clinically stable as ready to undergo a spontaneous breathing trial.
Treatment:
Diagnostic Test: Parasternal intercostal muscles thickness ultrasound indicies

Trial contacts and locations

1

Loading...

Central trial contact

Wesameldin A Soltan, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems